NAYA Biosciences Inc. (NAYA)
NASDAQ: NAYA
· Real-Time Price · USD
2.20
0.17 (8.37%)
At close: Apr 25, 2025, 3:59 PM
NAYA Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.9M | -9.1M | -7.47M | -7.08M | -7.08M | -8.03M | -8.81M | -10.11M | -10.67M | -10.89M | -8.27M | -7.96M | -6.98M | -6.65M | -10.32M | -9.85M | -9.36M |
Depreciation & Amortization | 927.11K | 919.6K | 829.39K | 619.4K | 408.77K | 258.75K | 194.71K | 251.31K | 310.82K | 306.32K | 308.12K | 262.6K | 214.94K | 151.05K | 80.31K | 57.54K | 34.53K |
Stock-Based Compensation | 1.45M | 1.59M | 1.6M | 1.76M | 658.85K | 445K | 265.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 371.56K | 501.67K | 201.78K | -610.43K | -207.61K | 24.95K | -115.87K | 604.12K | 624.25K | 350.66K | -3.04M | -3.13M | -3.47M | -3.67M | -887.96K | -973.02K | -961.58K |
Other Non-Cash Items | 15.9M | 1.75M | 1.57M | 1.68M | 1.94M | 2.1M | 2.3M | 2.51M | 2.69M | 2.73M | 3.72M | 3.64M | 3.46M | 4.08M | 4.83M | 5.08M | 5.05M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 810.00 | 810.00 | 810.00 | 810.00 | n/a | n/a | n/a | n/a | 36.00 | 36.00 | 36.00 |
Change in Working Capital | 368.56K | 1.86M | 394.24K | -648.94K | 204.69K | 471.7K | 999.49K | 1.9M | 1.99M | 1.25M | -2.87M | -3.01M | -3.07M | -3.61M | -924.8K | -961.4K | -1.37M |
Operating Cash Flow | -6.26M | -2.97M | -3.07M | -3.68M | -3.87M | -4.76M | -5.04M | -5.45M | -5.67M | -6.6M | -7.11M | -7.07M | -6.37M | -6.03M | -6.34M | -5.67M | -5.65M |
Capital Expenditures | -148.66K | -183.7K | -179.83K | -288.05K | -494.42K | -444.72K | -369.58K | -263.95K | -5.13K | -10.78K | 317.62K | -424.04K | -421.36K | -415.71K | -772.98K | -28.73K | -28.73K |
Cash Acquisitions | 472.01K | 472.01K | 108.29K | -2.04M | -2.04M | -2.04M | -2.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -8.45K | 1.00 | 1.00 | -1.61K | -68.49K | -1.52M | -1.78M | -1.77M | -1.7M | -318.29K | -98.08K | -98.08K |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 50K | 75.59K | 75.59K | 75.59K | 25.59K | n/a | n/a | n/a | n/a | n/a | 200K | 880K | 280K | n/a | -162.52K | -870.8K | -280K |
Investing Cash Flow | 373.35K | 363.89K | 4.05K | -2.25M | -2.51M | -2.49M | -2.52M | -264.38K | -7.77K | -81.22K | -1.01M | -1.32M | -1.93M | -2.15M | -1.33M | -1.07M | -471.1K |
Debt Repayment | -706.33K | 409.83K | -225.75K | 1.19M | 1.15M | 1.66M | 2.61M | 1.15M | 1.34M | 800K | -250K | -250K | -250K | -250K | -475K | 37.02K | 2.35M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 900.7K | 900.61K | 923.66K | 923.66K | 23.05K | 23.05K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 6.25M | 3.12M | 2.48M | 6.76M | 4.66M | 7.39M | 8.33M | 3.86M | 4.03M | 1.09M | 3.69M | 3.72M | 3.72M | 3.77M | 11.48M | 11.88M | 14.19M |
Net Cash Flow | 365.28K | 508.97K | -583.95K | 830.45K | 362.64K | 119.94K | 943.06K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Free Cash Flow | -6.41M | -3.16M | -3.25M | -3.97M | -4.36M | -5.2M | -5.41M | -5.71M | -5.68M | -6.61M | -6.79M | -7.5M | -6.79M | -6.45M | -7.11M | -5.7M | -5.68M |